MNOV – Medicinova Inc
MNOV — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
0.44
Margin Of Safety %
Put/Call OI Ratio
0.34
EPS Next Q Diff
-0.01
EPS Last/This Y
-0.06
EPS This/Next Y
-0.11
Price
1.42
Target Price
9
Analyst Recom
1
Performance Q
2.9
Upside
-319.7%
Beta
0.66
Ticker: MNOV
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | MNOV | 1.38 | 0.36 | 0.00 | 83 |
| 2026-03-10 | MNOV | 1.41 | 0.36 | 0.00 | 83 |
| 2026-03-11 | MNOV | 1.43 | 0.37 | 0.00 | 82 |
| 2026-03-12 | MNOV | 1.38 | 0.37 | 0.00 | 82 |
| 2026-03-13 | MNOV | 1.38 | 0.37 | 0.00 | 82 |
| 2026-03-17 | MNOV | 1.48 | 0.36 | 999.99 | 83 |
| 2026-03-18 | MNOV | 1.42 | 0.36 | 999.99 | 83 |
| 2026-03-20 | MNOV | 1.54 | 0.36 | 999.99 | 83 |
| 2026-03-25 | MNOV | 1.47 | 0.34 | 0.00 | 82 |
| 2026-03-26 | MNOV | 1.42 | 0.34 | 0.00 | 82 |
| 2026-03-27 | MNOV | 1.38 | 0.34 | 0.00 | 82 |
| 2026-03-30 | MNOV | 1.37 | 0.34 | 0.00 | 82 |
| 2026-03-31 | MNOV | 1.37 | N/A | N/A | 0 |
| 2026-04-01 | MNOV | 1.43 | 0.34 | 0.00 | 82 |
| 2026-04-06 | MNOV | 1.42 | 0.34 | 0.00 | 82 |
| 2026-04-07 | MNOV | 1.42 | 0.34 | 0.00 | 82 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | MNOV | 1.38 | -16.7 | - | -0.32 |
| 2026-03-10 | MNOV | 1.41 | -16.7 | - | -0.32 |
| 2026-03-11 | MNOV | 1.43 | -16.7 | - | -0.32 |
| 2026-03-12 | MNOV | 1.38 | -16.7 | - | -0.32 |
| 2026-03-13 | MNOV | 1.36 | -16.7 | - | -0.32 |
| 2026-03-17 | MNOV | 1.49 | -16.7 | - | -0.32 |
| 2026-03-18 | MNOV | 1.41 | -16.7 | -0.7 | -0.32 |
| 2026-03-19 | MNOV | 1.39 | -16.7 | -1.4 | -0.32 |
| 2026-03-20 | MNOV | 1.53 | -16.7 | -4.3 | -0.32 |
| 2026-03-23 | MNOV | 1.46 | -16.7 | -0.3 | -0.32 |
| 2026-03-24 | MNOV | 1.46 | -16.7 | -1.9 | -0.32 |
| 2026-03-25 | MNOV | 1.47 | -16.7 | -2.2 | -0.32 |
| 2026-03-26 | MNOV | 1.41 | -16.7 | -0.8 | -0.32 |
| 2026-03-27 | MNOV | 1.38 | -16.7 | -1.1 | -0.32 |
| 2026-03-30 | MNOV | 1.37 | 0.0 | -1.4 | -0.30 |
| 2026-03-31 | MNOV | 1.39 | 0.0 | -2.2 | -0.30 |
| 2026-04-01 | MNOV | 1.43 | 0.0 | -2.6 | -0.30 |
| 2026-04-02 | MNOV | 1.43 | 0.0 | -2.0 | -0.30 |
| 2026-04-06 | MNOV | 1.38 | 0.0 | -0.5 | -0.30 |
| 2026-04-07 | MNOV | 1.42 | 0.0 | -2.4 | -0.30 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | MNOV | 0.00 | 0.34 | 0.44 |
| 2026-03-10 | MNOV | 0.00 | 0.34 | 0.44 |
| 2026-03-11 | MNOV | 0.00 | 0.34 | 0.42 |
| 2026-03-12 | MNOV | 0.00 | 0.34 | 0.42 |
| 2026-03-13 | MNOV | 0.00 | 0.34 | 0.41 |
| 2026-03-18 | MNOV | 0.00 | 0.34 | 0.41 |
| 2026-03-19 | MNOV | 0.00 | 0.34 | 0.41 |
| 2026-03-20 | MNOV | 0.00 | 0.34 | 0.41 |
| 2026-03-23 | MNOV | 0.00 | 0.34 | 0.41 |
| 2026-03-24 | MNOV | 0.00 | 0.34 | 0.41 |
| 2026-03-25 | MNOV | 0.00 | 0.34 | 0.44 |
| 2026-03-26 | MNOV | 0.00 | 0.34 | 0.44 |
| 2026-03-27 | MNOV | 0.00 | 0.34 | 0.44 |
| 2026-03-30 | MNOV | 0.00 | 0.34 | 0.44 |
| 2026-03-31 | MNOV | 0.00 | 0.34 | 0.44 |
| 2026-04-01 | MNOV | 0.00 | 0.34 | 0.44 |
| 2026-04-02 | MNOV | 0.00 | 0.34 | 0.44 |
| 2026-04-06 | MNOV | 0.00 | 0.34 | 0.44 |
| 2026-04-07 | MNOV | 0.00 | 0.34 | 0.44 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.05
Avg. EPS Est. Current Quarter
-0.06
Avg. EPS Est. Next Quarter
-0.06
Insider Transactions
Institutional Transactions
0.34
Beta
0.66
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
27
Growth Score
24
Sentiment Score
95
Actual DrawDown %
72.5
Max Drawdown 5-Year %
-78
Target Price
9
P/E
Forward P/E
PEG
P/S
170.47
P/B
1.68
P/Free Cash Flow
EPS
-0.24
Average EPS Est. Cur. Y
-0.3
EPS Next Y. (Est.)
-0.41
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-2928.78
Relative Volume
0.25
Return on Equity vs Sector %
-56.3
Return on Equity vs Industry %
-39.8
EPS 1 7Days Diff
EPS 1 30Days Diff
0.02
EBIT Estimation
-2.4
◆
MNOV
Healthcare
$1.42
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
48.6
Range 1M
45%
Sup Dist
3%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-27.1%
EPS NY
-31.2%
52W%
31.8%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+533.8% upside
Upside
+533.8%
Quality
27
MediciNova, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 6
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, and glioblastoma, as well as prevention of acute respiratory distress syndrome. The company is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.
MNOV
Latest News
—
Caricamento notizie per MNOV…
stock quote shares MNOV – Medicinova Inc Stock Price stock today
news today MNOV – Medicinova Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MNOV – Medicinova Inc yahoo finance google finance
stock history MNOV – Medicinova Inc invest stock market
stock prices MNOV premarket after hours
ticker MNOV fair value insiders trading